Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinkui nasal spray is a Tibetan medicinal preparation developed by the People's Hospital of Tibet Autonomous Region for the treatment of nasal mucosal inflammatory diseases, including allergic rhinitis and chronic rhinosinusitis. The spray contains active ingredients derived from the Jinkui plant (likely *Malva verticillata* or a related species), which is utilized in traditional Tibetan medicine for its anti-inflammatory properties. It is currently being evaluated in clinical trials as an adjunctive therapy to standard guideline-recommended treatments to assess its safety, efficacy, and potential for product optimization in adults with inflammatory nasal conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinkui nasal spray.